These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
126 related items for PubMed ID: 8099249
21. The role of different biomarkers (DNA, PCNA, apoptosis and karyotype) in prognostic evaluation of superficial transitional cell bladder carcinoma. Lavezzi AM, Biondo B, Cazzullo A, Giordano F, Pallotti F, Turconi P, Matturri L. Anticancer Res; 2001; 21(2B):1279-84. PubMed ID: 11396199 [Abstract] [Full Text] [Related]
31. Expression of proliferative cell nuclear antigen (PCNA) in urinary bladder carcinoma. Evaluation of antigen retrieval methods. Malmström PU, Wester K, Vasko J, Busch C. APMIS; 1992 Nov; 100(11):988-92. PubMed ID: 1361755 [Abstract] [Full Text] [Related]
32. Argyrophilic nucleolar organizer region in proliferating cell has a predictive value for local recurrence in superficial bladder tumor. Tomobe M, Shimazui T, Uchida K, Hinotsu S, Akaza H. J Urol; 1999 Jul; 162(1):63-8. PubMed ID: 10379741 [Abstract] [Full Text] [Related]
33. Proliferating cell nuclear antigen (PCNA) expression in childhood lymphomas. Kalmanti M, Kanavaros P, Sakalidou A, Tzardi M, Datseris G, Bolonaki E, Kalmantis T, Kazlaris E, Delides G. Acta Morphol Hung; 1992 Jul; 40(1-4):215-21. PubMed ID: 1365765 [Abstract] [Full Text] [Related]
34. [Study of proliferating cell nuclear antigen (PCNA), nucleolar organizer regions (NORs) and mitotic activity in epithelial ovarian tumors]. Yamanaka S, Nagai N, Ohama K. Nihon Sanka Fujinka Gakkai Zasshi; 1993 Mar; 45(3):234-40. PubMed ID: 8098347 [Abstract] [Full Text] [Related]
35. The frequency of hydronephrosis at initial diagnosis and its effect on recurrence and progression in patients with superficial bladder cancer. Divrik RT, Sahin A, Altok M, Unlü N, Zorlu F. J Urol; 2007 Sep; 178(3 Pt 1):802-6; discussion 806. PubMed ID: 17632171 [Abstract] [Full Text] [Related]
36. [Monoclonal antibodies against transitional cell carcinoma assay tumor associated antigens in different grades bladder cancer patients]. Zhang H, Zhao Z, Sun H. Zhonghua Wai Ke Za Zhi; 1996 Sep; 34(9):560-2. PubMed ID: 9594163 [Abstract] [Full Text] [Related]
37. [Expression and clinical significance of PCNA in renal pelvic and ureteral cancer]. Kong C, Li Z, Liu T. Zhonghua Wai Ke Za Zhi; 1996 Oct; 34(10):614-6. PubMed ID: 9590738 [Abstract] [Full Text] [Related]
38. [The study of the ABH isoantigen of bladder tumors]. Fukatsu H, Nonomura H, Miyagawa Y, Waki M, Hatano Y, Hiraiwa S, Muramatsu T, Takamura T, Yamada Y, Nishikawa E. Hinyokika Kiyo; 1987 Jun; 33(6):857-63. PubMed ID: 3314420 [Abstract] [Full Text] [Related]